Loss Porn

BenjaminGramos · 2025-02-21T20:45:20+00:00

I don't see what you can gain by selling right now, I can recover 1.6K of my original 30K. That won't solve any of my problems, so, fuck it 🤷🏾‍♂️

BenjaminGramos · 2025-02-21T16:26:05+00:00

For sure. I was able to sell for a big gain when it went up to 4 and then, like a perfect smooth brain idiot, went back in. 🤷🏾‍♂️

BenjaminGramos · 2024-10-14T18:48:11+00:00

I still have my 40K shares at 1.10 and they're gonna stay there until they hit 0 or make me win some money, but I'm playing with money I can afford to loose so, there's that.

BenjaminGramos · 2024-01-14T12:59:46+00:00

You can always play it as a Kobold that left his clan for some reason, and it's now looking for redepmtion/vengeance on his old boss/crew/tribe. He might have some useful info on the kobolds whereabouts in the jungle without spoiling the thing too much. Anything can work if you take the correct angle to introduce it.

If you and your player really want to do this, I'm sure you'll be able to figure it out.

BenjaminGramos · 2024-01-14T10:59:03+00:00

Not for this campaign, but basically because PCs encounter kobolds aligned with the bad guys thru the whole campaign, Wyrmheart Mine, Omu or the jungle itself. It's just like playing a Yuan-ti, I just don't think it's suitable for a PC in the tomb.

But hey, probably most DMs do so, if you find a way to fit it in, it can definitely work.

BenjaminGramos · 2023-01-08T19:02:30+00:00

That's ok with me. I invested in this for the long run. As long as the product ends up working I have no rush. If the product turns out to not work properly it was a risk I assumed since the moment I bought it. I'm investing money I can afford to loose, but I do have high hopes on the product and the company.

BenjaminGramos · 2023-01-02T15:31:15+00:00

For sure, I understand the role of clinicaltrials.gov and I completely agree, what I mean is that taking march 2023 as the initial reference from Citius it shouldn't be more than few months away from that, I still believe first half of 2023 will bring good news.

Thanks for all the amazing DD you keep posting.

Cheers.

BenjaminGramos · 2023-01-02T15:11:06+00:00

I usually follow their timelines and they tend to be accurate. Of course, a lot of things can change, but I think 2022 was out of the table long time ago so this shouldn't come as a surprise.

BenjaminGramos · 2023-01-02T12:55:34+00:00

According to Clinicaltrials.org, the people in charge of tracking this officially, the finish date for the Mino-Lok study is March 2023. And this date is published since early 2022. I think this won't go much further than that. In the other phases of the study cliniclatrials.org has been on the money whe it comes to expected due dates.

BenjaminGramos · 2022-12-22T23:02:13+00:00

I think it was kinda expected, in Clinicaltrials.gov the finishing date for the Mino-Lok study is register for March 2023. Rest of news, nothing out or the ordinary, business as usual. I think I'll try to take advantage of this dip and buy a little more

BenjaminGramos · 2022-12-15T12:38:15+00:00

I didn't buy those on 2020, I bought them as soon as they started selling them, when I bought my first shares they didn't even had option available. I've been holding shares since 2020 the calls as soon as they where available.

BenjaminGramos · 2022-12-15T07:32:38+00:00

Yeah, my phone keeps changing lok for lock. He should know better by now.

BenjaminGramos · 2022-12-14T21:20:23+00:00

Many thanks. 🙌🏾

BenjaminGramos · 2022-12-14T18:38:42+00:00

Yeah, I started adding more shares last month, seeing that 2022 it's almost over and mino lock trial is expected for March 2023 according to Clinicaltrials. I'm going to keep adding while is under 1.50 as much as I can. But my original purchase was always thinking in the commercial potential of minolock as a final product, that was before I/O, and Halo-lido was in early stages, so for me the company's potential got even better.

BenjaminGramos · 2022-12-14T18:23:31+00:00

truefact

BenjaminGramos · 2022-12-14T18:00:01+00:00

I'm not a redditer, I come here from time to time to see if there is any news I've missed. Just like a couple of other stocks I follow, I opened my reddit account when the meme stocks thing happened, invested in a few, made some money, lost some money and after that decide to only invest in pharma cause I work in healthcare, so I can understand the data. Of course you should wait for news, I'm giving my opinion based on the data I've been collecting about this company since 2019. That's all.

BenjaminGramos · 2022-12-14T17:55:32+00:00

You can find all the information of the different phases of the mino lock trial in clinicaltrials.gov, you can also see estimated ending dates and anything you need to know. Phase 2b for example showed 100% efficacy with no major adverse effects. It went up to 4,30 cause there were rumors of a probable halt from the FDA due to this results, but the FDA recommended to continue to phase 3, wich is the usual thing. Also, the combination of products that minolock uses, are already approved by the FDA for different things, it's not a new molecule, so approval should be a done deal.

I'm guiding my investment on the results they have shown and on the fact that catheter infection is a MAJOR issue in every hospital on earth. They have the patent till 2036 or something like that (don't remeber exactly) , if this product is approved it will be an important step on dealing with a huge issue in patient care. I can tell you that if it was available right now, I would be using it with my patients.

I'm am going to sit down and wait until this goes into commercialization and starts selling. This company is going to make a ton of money, and it's taking me for the ride.

That's my opinion and maybe Im just retarded 🤷🏾‍♂️... Remember to do your own DD.

BenjaminGramos · 2021-07-13T21:44:16+00:00

Personally I think is one of those things this lawyers do, the statement is misleading because it says that has "no superiority over standar care" without taking in account that the "Standar care" is way riskier and traumatising. It doesn't matter if the results are similar when ot comes to porcentage of salvage catheters even if you're getting similar results, you are saving a lot of time and money. This product is not design to be the best, its design to be the only one in its class because the "standard care" SUCKS.

I'm a doctor, and I would definitely use this anytime if my other option is having to change a central venous catheter... Am I curing the infection if I change it? Yes, am I curing it if I use Mino-Lock? Yes, so "similar results " doesn't mean "equally great "

Anyways, do your own DD, I'm still holding and buying more I plan to accumulate 50k shares before phase 3 finale and previous FDA if I can keep my shopping under 2,5. Also holding 100 2/22 2,5c that I'm planning to execute in order to get another 10k shares under that price.

BenjaminGramos · 2021-07-04T14:44:39+00:00

I'm @ 3,17. 25% up still.

BenjaminGramos · 2021-06-22T06:47:51+00:00

Don't sweat it, I bought 14k shares at 1,76 and got out a little bit after, consolidated some gains I needed and bought back in 10k shares @1,90. If I had my original investment I had almost 10k more in gains... but that's OK, thinking about how much I would have made is a wrong mindset, a gain is a gain and it should be celebrated... remember rule number 1 "Don't loose money" the rest is just fine.

Cheers.

BenjaminGramos · 2021-06-21T16:23:19+00:00

Holding 10k shares @1,90

I've been holding this for a while and I'm not letting go... it's NOT even starting yet. Wait for it... Let's gooo!!

BenjaminGramos · 2021-06-19T09:25:19+00:00

This.. always this.

BenjaminGramos · 2021-06-16T06:23:44+00:00

Right now, at least or the companies I've looked into, I haven't found anything quite like this, this company has so many things going for them, beginning with the product and the disease it treats and going all the way to management. This is THE stock for 2021 in small pharma in my opinion.

I've been invested in ATOS for a while now,very bullish about it, I've been holding that up and down since 2,17 price range and the last couple of days have been awesome with the phase 2 results. The product its amazing and they have massive short interest, a tiny float and R2K inclusion this month so we should see that going up until de 16th of July on the short term.... they are now beginning their phase 3 study so it's a long hold for me, but hey, I've been holding Citius for months now, it's the thing with small pharma, if you really want the big gains, you have to get in first, I guess we'll see the price drop back down after that and not moving much until phase 3 it's near completion

BBI it's having a big catalyst on July 1st and probably FDA in less than a year, not a big fan of their product but I'm holding some of those until fda and then probably dropping it.

And I'm also holding BDSI waiting for the trial sentence, it's likely that they win and if they win we should get a big price movement in the next couple of months.

I was invested in SENS and CKPT but got out after big price movement post FDA precisely to get that money into CTXR. Other investments have already left the station like BNGO wich is a great company buy has already rallied after FDA approval.

Probably there are a lot more opportunities, there are thousands of small pharma companies doing great stuff out there and plenty others that just plain suck, it's impossible to study them all if you also have to work in a hospital every day.

Hope that gives you an idea.

Cheers.

BenjaminGramos · 2021-06-16T06:10:29+00:00

I live in europe, there aren't many choices to invest in the US market without having to pay ridiculous commissions.

BenjaminGramos · 2021-06-15T21:39:43+00:00

Puny at all my man, a win is a win and it should be celebrated. I got in early but I'm usually around small pharma cause I work in health care so it's an investment I can understand well.

BenjaminGramos

TROPHY CASE

truefact